Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 5Recruiting 4Unknown 3Active not recruiting 3Terminated 2Withdrawn 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Pituitary Neoplasms 1Language Disorders 1Headache 1Brain Neoplasms 1Acromegaly 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Transcranial Magnetic Stimulation × Clear all
NCT04501731 2022-05-25

5C-pilot

University of Nottingham

Unknown
10 enrolled
CNS

Brain Neoplasms

NCT04529356 2020-08-27

The TMS Treatment for Postoperative Headache in GH Tumor

Huashan Hospital

Phase NA Unknown
200 enrolled
Endocrine

Acromegaly, Headache, Pituitary Neoplasms

NCT03974659 2019-06-05

Enhanced Recovery After Surgery Using TMS on Cerebellar Language Area for Brain Tumor Patients

Huashan Hospital

Phase NA Unknown
106 enrolled

Language Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡